Resveratrol inhibits migration and invasion of human breast-cancer cells

Molecular Nutrition and Food Research

Volumn 52, Issue 6, 2008, Pages 683-691

  Tang, Feng Yao ^a   Su, Yu Ching ^a   Chen, Nai Chia ^a   Hsieh, Hui Shan ^a   Chen, Kaun Suei ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Breast cancer cells; Invasion; Matrix metalloproteinase; Migration; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; GELATINASE A; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RESVERATROL; SOMATOMEDIN C; STILBENE DERIVATIVE;

ARTICLE; BREAST TUMOR; CANCER INVASION; CELL MOTION; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; STILBENES;

EID: 49649109340     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700325     Document Type: Article

References (37)

1. Jemal, A., Murray, T., Ward, E., Samuels, A., et al., Cancer statistics, CA Cancer J. Clin. 2005, 55, 10-30.
2. Friedel, G., Pastorino, U., Ginsberg, R. J., Goldstraw, P,. et al., Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur. J. Cardiothorac. Surg. 2002, 22, 335-344.
3. Baserga, R., Peruzzi, F., Reiss, K., The IGF-1 receptor in cancer biology. Int. J. Cancer 2003, 107, 873-877.
4. Lonning, P. E., Helle, S. I., IGF-1 and breast cancer. Novartis Found. Symp. 2004 262, 205-212.
5. Rinaldi, S., Kaaks, R., Zeleniuch-Jacquotte, A., Arslan, A. A., et al., Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 48-52.
6. Bartucci, M., Morelli, C., Mauro, L., Ando', S., Surmacz, E., Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast-cancer cells. Cancer Res. 2001, 61, 6747-6754.
7. Vaira, V., Lee, C.W., Goel, H. L., Bosari, S., et al., Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene 2007, 26, 2678-2684.
8. Wang, Z., Fukuda, S., Pelus, L. M., Survivin regulates the p53 tumor suppressor gene family. Oncogene 2004, 23, 8146-8153.
9. Formby, B., Wiley, T. S., Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast-cancer cells by progesterone: inhibition of cell growth and induction of apoptosis. Mol. Cell Biochem. 1999, 202, 53-61.
10. Sachdev, D., Hartell, J. S., Lee, A. V., Zhang, X., Yee, D., A dominant negative type I insulin-like growth factor receptor inhibits metastasis of human cancer cells. J. Biol. Chem. 2004, 279, 5017-5024.
11. Zhang, D., Bar-Eli, M., Meloche, S., Brodt, P., Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals. J. Biol. Chem. 2004, 279, 19683-19690.
12. Johansson, N., Ahonen, M., Kahari, V. M., Matrix metalloproteinases in tumor invasion. Cell Mol. Life Sci. 2000, 57, 5-15.
13. Sternlicht, M. D., Werb, Z., How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 2001, 17, 463-516.
14. Brinckerhoff, C. E., Matrisian, L. M., Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 2002, 3, 207-214.
15. Allgayer, H., Babic, R., Beyer, B. C., Grutzner, K. U., et al., Prognostic relevance of MMP-2 (72-kDa collagenase IV) in gastric cancer. Oncology 1998, 55, 152-160.
16. Ellenrieder, V., Alber, B., Lacher, U., Hendler, S. F., et al., Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int. J. Cancer 2000, 85, 14-20.
17. Hanemaaijer, R., Verheijen, J. H., Maguire, T. M., Visser, H., et al., Increased gelatinase-A and gelatinase-B activities in malignant vs. benign breast tumors. Int. J. Cancer 2000, 86, 204-207.
18. Kanayama, H., Matrix metalloproteinases and bladder cancer. J. Med. Invest. 2001, 48, 31-43.
19. Shimada, T., Nakamura, H., Yamashita, K., Kawata, R., et al., Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis. Clin. Exp. Metastasis 2000, 18, 179-188.
20. Tang, F. Y., Nguyen, N., Meydani, M., Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int. J. Cancer 2003, 106, 871-878.
21. Bemis, D. L., Katz, A. E., Buttyan, R., Clinical trials of natural products as chemopreventive agents for prostate cancer. Expert. Opin. Investig. Drugs 2006, 15, 1191-1200.
22. Aggarwal, B. B., Shishodia, S., Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 2006, 71, 1397-1421.
23. Levi, F., Pasche, C., Lucchini, F., Ghidoni, R., et al., Resveratrol and breast cancer risk. Eur. J. Cancer Prev. 2005, 14, 139-142.
24. Le Corre, L., Chalabi, N., Delort, L., Bignon, Y. J., Bernard-Gallon, D. J., Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol. Nutr. Food Res. 2005, 49, 462-471.
25. Tang, F. Y., Chiang, E. P., Sun, Y. C., Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast-cancer cells. J. Nutr. Biochem. 2008 (in press).
26. Repesh, L. A., A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989, 9, 192-208.
27. Nielsen-Preiss, S. M., Allen, M. P., Xu, M., Linseman, D. A., et al., Adhesion-related kinase induction of migration requires phosphatidylinositol-3-kinase and ras stimulation of rac activity in immortalized gonadotropin-releasing hormone neuronal cells. Endocrinology 2007, 148, 2806-2814.
28. Tang, F. Y., Chiang, E. P., Shih, C. J., Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells. J. Nutr. Biochem. 2007, 18, 391-399.
29. Athar, M., Back, J. H., Tang, X., Kim, K. H., et al., Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharmacol. 2007, 224, 274-283.
30. Stewart, J. R., Artime, M. C., O'Brian, C. A., Resveratrol: a candidate nutritional substance for prostate cancer prevention. J. Nutr. 2003, 133, 2440S-2443S.
31. Sliva, D., Rizzo, M. T., English, D., Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast-cancer cells by the secretion of urokinase-type plasminogen activator. J. Biol. Chem. 2002, 277, 3150-3157.
32. Guvakova,M. A., Adams, J. C., Boettiger, D., Functional role of alpha-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells. J. Cell Sci. 2002, 115, 4149-4165.
33. Bahr, C., Groner, B., The IGF-1 receptor and its contributions to metastatic tumor growth-novel approaches to the inhibition of IGF-1R function. Growth Factors 2005, 23, 1-14.
34. Gehm, B. D., McAndrews, J. M., Chien, P. Y., Jameson, J. L., Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 1997, 94, 14138-14143.
35. Levenson, A. S., Gehm, B. D., Pearce, S. T., Horiguchi, J., et al., Resveratrol acts as an estrogen receptor (ER) agonist in breast-cancer cells stably transfected with ER alpha. Int. J. Cancer 2003, 104, 587-596.
36. Vyas, S., Asmerom, Y., De Leon, D. D., Resveratrol regulates insulin-like growth factor-II in breast-cancer cells. Endocrinology 2005, 146, 4224-4233.
37. Zhao, M., Mueller, B. M., Discipio, R. G., Schraufstatter, I. U., Akt plays an important role in breast-cancer cell chemotaxis to CXCL12. Breast Cancer Res. Treat. 2008 (in press).